290 related articles for article (PubMed ID: 34489931)
1. Selective Binding of Heparin/Heparan Sulfate Oligosaccharides to Factor H and Factor H-Related Proteins: Therapeutic Potential for C3 Glomerulopathies.
Loeven MA; Maciej-Hulme ML; Yanginlar C; Hubers MC; Kellenbach E; de Graaf M; van Kuppevelt TH; Wetzels J; Rabelink TJ; Smith RJH; van der Vlag J
Front Immunol; 2021; 12():676662. PubMed ID: 34489931
[TBL] [Abstract][Full Text] [Related]
2. Complement Factor H-Related Proteins FHR1 and FHR5 Interact With Extracellular Matrix Ligands, Reduce Factor H Regulatory Activity and Enhance Complement Activation.
Papp A; Papp K; Uzonyi B; Cserhalmi M; Csincsi ÁI; Szabó Z; Bánlaki Z; Ermert D; Prohászka Z; Erdei A; Ferreira VP; Blom AM; Józsi M
Front Immunol; 2022; 13():845953. PubMed ID: 35392081
[TBL] [Abstract][Full Text] [Related]
3. Mutations in Complement Factor H Impair Alternative Pathway Regulation on Mouse Glomerular Endothelial Cells in Vitro.
Loeven MA; Rops AL; Lehtinen MJ; van Kuppevelt TH; Daha MR; Smith RJ; Bakker M; Berden JH; Rabelink TJ; Jokiranta TS; van der Vlag J
J Biol Chem; 2016 Mar; 291(10):4974-81. PubMed ID: 26728463
[TBL] [Abstract][Full Text] [Related]
4. C3 glomerulopathy-associated CFHR1 mutation alters FHR oligomerization and complement regulation.
Tortajada A; Yébenes H; Abarrategui-Garrido C; Anter J; García-Fernández JM; Martínez-Barricarte R; Alba-Domínguez M; Malik TH; Bedoya R; Cabrera Pérez R; López Trascasa M; Pickering MC; Harris CL; Sánchez-Corral P; Llorca O; Rodríguez de Córdoba S
J Clin Invest; 2013 Jun; 123(6):2434-46. PubMed ID: 23728178
[TBL] [Abstract][Full Text] [Related]
5. Disturbed sialic acid recognition on endothelial cells and platelets in complement attack causes atypical hemolytic uremic syndrome.
Hyvärinen S; Meri S; Jokiranta TS
Blood; 2016 Jun; 127(22):2701-10. PubMed ID: 27006390
[TBL] [Abstract][Full Text] [Related]
6. Complement Factor H related protein 1 and immune inflammatory disorders.
Li X; Zong J; Si S
Mol Immunol; 2022 May; 145():43-49. PubMed ID: 35279539
[TBL] [Abstract][Full Text] [Related]
7. Human factor H-related protein 5 has cofactor activity, inhibits C3 convertase activity, binds heparin and C-reactive protein, and associates with lipoprotein.
McRae JL; Duthy TG; Griggs KM; Ormsby RJ; Cowan PJ; Cromer BA; McKinstry WJ; Parker MW; Murphy BF; Gordon DL
J Immunol; 2005 May; 174(10):6250-6. PubMed ID: 15879123
[TBL] [Abstract][Full Text] [Related]
8. Complement C3b/C3d and cell surface polyanions are recognized by overlapping binding sites on the most carboxyl-terminal domain of complement factor H.
Hellwage J; Jokiranta TS; Friese MA; Wolk TU; Kampen E; Zipfel PF; Meri S
J Immunol; 2002 Dec; 169(12):6935-44. PubMed ID: 12471127
[TBL] [Abstract][Full Text] [Related]
9. Atypical Hemolytic Uremic Syndrome-Associated FHR1 Isoform FHR1*B Enhances Complement Activation and Inflammation.
Xu B; Kang Y; Du Y; Guo W; Zhu L; Zhang H
Front Immunol; 2022; 13():755694. PubMed ID: 35126388
[TBL] [Abstract][Full Text] [Related]
10. Mutations of factor H impair regulation of surface-bound C3b by three mechanisms in atypical hemolytic uremic syndrome.
Lehtinen MJ; Rops AL; Isenman DE; van der Vlag J; Jokiranta TS
J Biol Chem; 2009 Jun; 284(23):15650-8. PubMed ID: 19351878
[TBL] [Abstract][Full Text] [Related]
11. Deregulation of Factor H by Factor H-Related Protein 1 Depends on Sialylation of Host Surfaces.
Dopler A; Stibitzky S; Hevey R; Mannes M; Guariento M; Höchsmann B; Schrezenmeier H; Ricklin D; Schmidt CQ
Front Immunol; 2021; 12():615748. PubMed ID: 33732239
[TBL] [Abstract][Full Text] [Related]
12. A novel atypical hemolytic uremic syndrome-associated hybrid CFHR1/CFH gene encoding a fusion protein that antagonizes factor H-dependent complement regulation.
Valoti E; Alberti M; Tortajada A; Garcia-Fernandez J; Gastoldi S; Besso L; Bresin E; Remuzzi G; Rodriguez de Cordoba S; Noris M
J Am Soc Nephrol; 2015 Jan; 26(1):209-19. PubMed ID: 24904082
[TBL] [Abstract][Full Text] [Related]
13. The MFHR1 Fusion Protein Is a Novel Synthetic Multitarget Complement Inhibitor with Therapeutic Potential.
Michelfelder S; Fischer F; Wäldin A; Hörle KV; Pohl M; Parsons J; Reski R; Decker EL; Zipfel PF; Skerka C; Häffner K
J Am Soc Nephrol; 2018 Apr; 29(4):1141-1153. PubMed ID: 29335241
[TBL] [Abstract][Full Text] [Related]
14. The binding of factor H to a complex of physiological polyanions and C3b on cells is impaired in atypical hemolytic uremic syndrome.
Ferreira VP; Herbert AP; Cortés C; McKee KA; Blaum BS; Esswein ST; Uhrín D; Barlow PN; Pangburn MK; Kavanagh D
J Immunol; 2009 Jun; 182(11):7009-18. PubMed ID: 19454698
[TBL] [Abstract][Full Text] [Related]
15. Gain-of-function factor H-related 5 protein impairs glomerular complement regulation resulting in kidney damage.
Malik TH; Gitterman DP; Lavin DP; Lomax-Browne HJ; Hiemeyer EC; Moran LB; Boroviak K; Cook HT; Gilmore AC; Mandwie M; Ahmad A; Alexander IE; Logan GJ; Marchbank KJ; Bradley A; Pickering MC
Proc Natl Acad Sci U S A; 2021 Mar; 118(13):. PubMed ID: 33753502
[TBL] [Abstract][Full Text] [Related]
16. Tissue-specific host recognition by complement factor H is mediated by differential activities of its glycosaminoglycan-binding regions.
Clark SJ; Ridge LA; Herbert AP; Hakobyan S; Mulloy B; Lennon R; Würzner R; Morgan BP; Uhrín D; Bishop PN; Day AJ
J Immunol; 2013 Mar; 190(5):2049-57. PubMed ID: 23365078
[TBL] [Abstract][Full Text] [Related]
17. Binding of complement factor H to endothelial cells is mediated by the carboxy-terminal glycosaminoglycan binding site.
Jokiranta TS; Cheng ZZ; Seeberger H; Jòzsi M; Heinen S; Noris M; Remuzzi G; Ormsby R; Gordon DL; Meri S; Hellwage J; Zipfel PF
Am J Pathol; 2005 Oct; 167(4):1173-81. PubMed ID: 16192651
[TBL] [Abstract][Full Text] [Related]
18. Defining the Glycosaminoglycan Interactions of Complement Factor H-Related Protein 5.
Gyapon-Quast F; Goicoechea de Jorge E; Malik T; Wu N; Yu J; Chai W; Feizi T; Liu Y; Pickering MC
J Immunol; 2021 Jul; 207(2):534-541. PubMed ID: 34193601
[TBL] [Abstract][Full Text] [Related]
19. MASP-2 Is a Heparin-Binding Protease; Identification of Blocking Oligosaccharides.
Talsma DT; Poppelaars F; Dam W; Meter-Arkema AH; Vivès RR; Gál P; Boons GJ; Chopra P; Naggi A; Seelen MA; Berger SP; Daha MR; Stegeman CA; van den Born J;
Front Immunol; 2020; 11():732. PubMed ID: 32425936
[TBL] [Abstract][Full Text] [Related]
20. Hemolysis is associated with altered heparan sulfate of the endothelial glycocalyx and with local complement activation in thrombotic microangiopathies.
Laboux T; Maanaoui M; Allain F; Boulanger E; Denys A; Gibier JB; Glowacki F; Grolaux G; Grunenwald A; Howsam M; Lancel S; Lebas C; Lopez B; Roumenina L; Provôt F; Gnemmi V; Frimat M
Kidney Int; 2023 Aug; 104(2):353-366. PubMed ID: 37164260
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
